Anjac Health & Beauty GROUP has acquired PharmaLinea for an undisclosed amount. This corporate acquisition sees Anjac, a prominent entity in the health and beauty sector, integrate PharmaLinea, a specialized developer and manufacturer of clinically supported private label food supplements. The transaction signifies a strategic move to expand Anjac's capabilities and market presence in the global wellness industry.
PharmaLinea distinguishes itself by developing and manufacturing private label food supplements backed by rigorous clinical evidence. Its portfolio addresses various health indications, including iron deficiency, immunity, urinary tract health, fertility, sleep, and bone health, among others. Present in over 40 international markets, PharmaLinea's products are chosen by major global groups, such as STADA and Teva, for their differentiation and clinical substantiation, which resonates with medical professionals. The company prides itself on conducting high-quality clinical trials on its finished products.
This acquisition is set to enhance Anjac Health & Beauty GROUP's offering by integrating PharmaLinea’s expertise in clinically validated private label solutions. The strategic rationale centers on diversifying Anjac’s product range and strengthening its position in the rapidly evolving nutraceutical market. Synergies are expected through combining Anjac's existing infrastructure with PharmaLinea's specialized research and development capabilities and established global distribution network for premium supplements.
The combination of Anjac's broader health and beauty focus with PharmaLinea's deep specialization in evidence-based food supplements is anticipated to create a more comprehensive and competitive entity. The unified group aims to leverage PharmaLinea's strong reputation for clinical substantiation and private label differentiation to accelerate growth and meet increasing consumer demand for effective, high-quality wellness products worldwide.